Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2018 argue for brigatinib as a first-line treatment option for advanced...
Post
Study: Antibiotics destroy immune cells and worsen oral infection
CASE WESTERN RESERVE UNIVERSITY New research shows that the body’s own microbes are effective in maintaining immune cells and killing certain oral infections. A team of Case Western Reserve University researchers found that antibiotics actually kill the “good” bacteria keeping infection and inflammation at bay. Scientists have long known that overuse of antibiotics can do...
Post
“Spray-On Skin” from AVITA Medical Approved to Treat Serious Burns
AVITA Medical, a Valencia, California firm, won FDA approval for its remarkable RECELL Autologous Cell Harvesting Device for serious burns in adult patients. In preparation for treatment, a small healthy piece of the patient’s skin sample is taken, from which the so-called “Spray-On Skin” preparation is made. The process only takes 30 minutes, so it...
Post
Researchers evaluate controversial treatment for Parkinson’s disease psychosis
Novel drug has been linked to increased mortality, but UC San Diego scientists find no statistically significant evidence in study comparing pimavanserin (Nuplazid) to another drug and to combination therapy UNIVERSITY OF CALIFORNIA – SAN DIEGO In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson’s...
Post
Vuzix Smart Glasses and Genzõ App Provide Live Life Experiences for Low-Mobility Patients
Vuzix, a New York-based supplier of smart glasses and augmented reality solutions, has partnered with 1Minuut Innovation, a Dutch healthcare innovation company, to provide a real-time life experience solution for low-mobility patients. The system consists of the Vuzix M300 smart glasses and the 1Minuut Genzõ app, and it allows patients who are confined to their...
Post
Inexpensive TB test holds promise for low-income countries
Study shows diagnostic test effective, easy to employ in Malawi COLUMBUS, Ohio – A low-cost, easy-to-replicate test for tuberculosis might help developing nations better identify and treat the infectious and sometimes deadly disease, new research suggests. A study of the $2 test in rural Malawi in southeastern Africa found that it was reliable and could...
Post
The genomic crash: researchers could reclassify over 4000 genes as non
A new study suggests that 20% of the previously accepted human genome has been misinterpreted and actually consists of non-coding DNA. Recent research led by Michael Tress of the Spanish National Cancer Research Centre (Madrid, Spain), has discovered that up to 4234 genes previously characterized as exons, could actually consist of non-coding DNA. The research,...
Post
Genomic dark matter activity connects Parkinson’s and psychiatric diseases
Comprehensive study reveals an expanding universe of ‘darkest of the dark matter‘ RNAs in dopamine-producing cells in our brains BRIGHAM AND WOMEN’S HOSPITAL Dopamine neurons are located in the midbrain, but their tendril-like axons can branch far into the higher cortical areas, influencing how we move and how we feel. New genetic evidence has revealed that these...
Post
Genomic study brings us closer to precision medicine for type 2 diabetes
Most patients diagnosed with type 2 diabetes are treated with a “one-size-fits-all” protocol that is not tailored to each person’s physiology and may leave many cases inadequately managed. A new study by scientists at the Broad Institute of MIT and Harvard and Massachusetts General Hospital (MGH) indicates that inherited genetic changes may underlie the variability...